English
简体中文
Total: £ 56.28
Published Date: 2026-03-12 | Pages: 119 | Tables: 119 | Medical Care
The global Sample Preparation in Genomics, Proteomics, and Epigenomics market was valued at US$ 184 million in 2025 and is anticipated to reach US$ 270 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Sample preparation in Genomics, Proteomics, and Epigenomics refers to a series of operations that isolate and transform target molecules from raw samples such as tissues or cells to adapt them for downstream high-throughput detection. In genomics, the core of preparation lies in obtaining high-purity, intact DNA through lysis and purification, and then fragmenting it to construct sequencing libraries. Preparation in proteomics is more complex, requiring quantification and enzymatic digestion of proteins after extraction to break them down into peptides, and often necessitating the removal of high-abundance interfering proteins to ensure the sensitivity of mass spectrometry detection. Epigenomics preparation, in addition to these steps, requires the preservation of epigenetic modification information, such as cross-linking chromatin to study protein-DNA interactions, or using bisulfite treatment to convert unmethylated cytosine, thereby locating methylation sites during sequencing. Furthermore, in epigenetic studies involving RNA, degradation must be strictly prevented. The preparation processes for all three require precise optimization based on the specific molecular targets and analytical platforms.
The global market for Sample Preparation in Genomics, Proteomics, and Epigenomics exhibits a pattern of both technological leadership and regional specialization. North America, leveraging its leading instrument companies and large-scale automated platforms, dominates the development of standardized preparation technologies for high-throughput, low-loss samples, maintaining a leading position, particularly in single-cell and micro-sample preparation. Europe, drawing on its deep foundation in structural biology and proteomics, focuses on handling challenging samples, such as membrane protein extraction and post-translational modification enrichment, emphasizing precision and reproducibility. The Asia-Pacific region, with China at its core, is driven by substantial research demand, rapidly emerging in the manufacturing of magnetic bead purification reagents and automated liquid handling workstations, providing cost-effective solutions and gradually moving from import substitution to technology export.
This report delivers a comprehensive overview of the global Sample Preparation in Genomics, Proteomics, and Epigenomics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sample Preparation in Genomics, Proteomics, and Epigenomics. The Sample Preparation in Genomics, Proteomics, and Epigenomics market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sample Preparation in Genomics, Proteomics, and Epigenomics market comprehensively. Regional market sizes by Type, by Application, by Technology Platform, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sample Preparation in Genomics, Proteomics, and Epigenomics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
QIAGEN GmbH
Bio-Rad Laboratories, Inc.
Danaher Corporation
Merck KGaA
PerkinElmer, Inc.
BGI
Cytiva
Illumina
Roche Sequencing Solutions
New England Biolabs
Thermo Fisher Scientific
Miltenyi Biotec
Twist Bioscience
Segment by Type
DNA Sample Preparation
RNA Sample Preparation
Protein Sample Preparation
Epigenetic Modification Targeted Preparation
Others
Segment by Technology Platform
Sequencing Platform Pretreatment
Mass Spectrometry Platform Pretreatment
Microarray Hybridization Pretreatment
PCR Platform Pretreatment
Others
Segment by Complexity
All Components Preparation
Subcellular Components Preparation
Modified and Enriched Components Preparation
Others
Segment by Application
Academic Institutes, and Government Institutes
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technology Platform, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Sample Preparation in Genomics, Proteomics, and Epigenomics companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 DNA Sample Preparation
1.2.3 RNA Sample Preparation
1.2.4 Protein Sample Preparation
1.2.5 Epigenetic Modification Targeted Preparation
1.2.6 Others
1.3 Market by Technology Platform
1.3.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Technology Platform: 2021 vs 2025 vs 2032
1.3.2 Sequencing Platform Pretreatment
1.3.3 Mass Spectrometry Platform Pretreatment
1.3.4 Microarray Hybridization Pretreatment
1.3.5 PCR Platform Pretreatment
1.3.6 Others
1.4 Market by Complexity
1.4.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Complexity: 2021 vs 2025 vs 2032
1.4.2 All Components Preparation
1.4.3 Subcellular Components Preparation
1.4.4 Modified and Enriched Components Preparation
1.4.5 Others
1.5 Market by Application
1.5.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Academic Institutes, and Government Institutes
1.5.3 Hospitals and Clinics
1.5.4 Pharmaceutical and Biotechnology Companies
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Perspective (2021–2032)
2.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Growth Trends by Region
2.2.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Sample Preparation in Genomics, Proteomics, and Epigenomics Historic Market Size by Region (2021–2026)
2.2.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Forecasted Market Size by Region (2027–2032)
2.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Dynamics
2.3.1 Sample Preparation in Genomics, Proteomics, and Epigenomics Industry Trends
2.3.2 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Drivers
2.3.3 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Challenges
2.3.4 Sample Preparation in Genomics, Proteomics, and Epigenomics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sample Preparation in Genomics, Proteomics, and Epigenomics Players by Revenue
3.1.1 Global Top Sample Preparation in Genomics, Proteomics, and Epigenomics Players by Revenue (2021–2026)
3.1.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Players (2021–2026)
3.2 Global Top Sample Preparation in Genomics, Proteomics, and Epigenomics Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue
3.4 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Concentration Ratio
3.4.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue in 2025
3.5 Global Key Players of Sample Preparation in Genomics, Proteomics, and Epigenomics Head Offices and Areas Served
3.6 Global Key Players of Sample Preparation in Genomics, Proteomics, and Epigenomics, Products and Applications
3.7 Global Key Players of Sample Preparation in Genomics, Proteomics, and Epigenomics, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Sample Preparation in Genomics, Proteomics, and Epigenomics Breakdown Data by Type
4.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Historic Market Size by Type (2021–2026)
4.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Forecasted Market Size by Type (2027–2032)
5 Sample Preparation in Genomics, Proteomics, and Epigenomics Breakdown Data by Application
5.1 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Historic Market Size by Application (2021–2026)
5.2 Global Sample Preparation in Genomics, Proteomics, and Epigenomics Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size (2021–2032)
6.2 North America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (2021–2026)
6.4 North America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size (2021–2032)
7.2 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (2021–2026)
7.4 Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size (2021–2032)
8.2 Asia-Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Region (2021–2026)
8.4 Asia-Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size (2021–2032)
9.2 Latin America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (2021–2026)
9.4 Latin America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size (2021–2032)
10.2 Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (2021–2026)
10.4 Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QIAGEN GmbH
11.1.1 QIAGEN GmbH Company Details
11.1.2 QIAGEN GmbH Business Overview
11.1.3 QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.1.4 QIAGEN GmbH Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.1.5 QIAGEN GmbH Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Details
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Details
11.3.2 Danaher Corporation Business Overview
11.3.3 Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.3.4 Danaher Corporation Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.3.5 Danaher Corporation Recent Development
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.4.4 Merck KGaA Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.4.5 Merck KGaA Recent Development
11.5 PerkinElmer, Inc.
11.5.1 PerkinElmer, Inc. Company Details
11.5.2 PerkinElmer, Inc. Business Overview
11.5.3 PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.5.4 PerkinElmer, Inc. Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.5.5 PerkinElmer, Inc. Recent Development
11.6 BGI
11.6.1 BGI Company Details
11.6.2 BGI Business Overview
11.6.3 BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.6.4 BGI Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.6.5 BGI Recent Development
11.7 Cytiva
11.7.1 Cytiva Company Details
11.7.2 Cytiva Business Overview
11.7.3 Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.7.4 Cytiva Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.7.5 Cytiva Recent Development
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Illumina Business Overview
11.8.3 Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.8.4 Illumina Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.8.5 Illumina Recent Development
11.9 Roche Sequencing Solutions
11.9.1 Roche Sequencing Solutions Company Details
11.9.2 Roche Sequencing Solutions Business Overview
11.9.3 Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.9.4 Roche Sequencing Solutions Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.9.5 Roche Sequencing Solutions Recent Development
11.10 New England Biolabs
11.10.1 New England Biolabs Company Details
11.10.2 New England Biolabs Business Overview
11.10.3 New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.10.4 New England Biolabs Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.10.5 New England Biolabs Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.11.4 Thermo Fisher Scientific Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Miltenyi Biotec
11.12.1 Miltenyi Biotec Company Details
11.12.2 Miltenyi Biotec Business Overview
11.12.3 Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.12.4 Miltenyi Biotec Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.12.5 Miltenyi Biotec Recent Development
11.13 Twist Bioscience
11.13.1 Twist Bioscience Company Details
11.13.2 Twist Bioscience Business Overview
11.13.3 Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Introduction
11.13.4 Twist Bioscience Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
11.13.5 Twist Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of DNA Sample Preparation
Table 3. Key Players of RNA Sample Preparation
Table 4. Key Players of Protein Sample Preparation
Table 5. Key Players of Epigenetic Modification Targeted Preparation
Table 6. Key Players of Others
Table 7. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Technology Platform (US$ Million): 2021 vs 2025 vs 2032
Table 8. Key Players of Sequencing Platform Pretreatment
Table 9. Key Players of Mass Spectrometry Platform Pretreatment
Table 10. Key Players of Microarray Hybridization Pretreatment
Table 11. Key Players of PCR Platform Pretreatment
Table 12. Key Players of Others
Table 13. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Complexity (US$ Million): 2021 vs 2025 vs 2032
Table 14. Key Players of All Components Preparation
Table 15. Key Players of Subcellular Components Preparation
Table 16. Key Players of Modified and Enriched Components Preparation
Table 17. Key Players of Others
Table 18. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 20. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Region (US$ Million), 2021–2026
Table 21. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Region (2021–2026)
Table 22. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Forecasted Market Size by Region (US$ Million), 2027–2032
Table 23. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Region (2027–2032)
Table 24. Sample Preparation in Genomics, Proteomics, and Epigenomics Market Trends
Table 25. Sample Preparation in Genomics, Proteomics, and Epigenomics Market Drivers
Table 26. Sample Preparation in Genomics, Proteomics, and Epigenomics Market Challenges
Table 27. Sample Preparation in Genomics, Proteomics, and Epigenomics Market Restraints
Table 28. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue by Players (US$ Million), 2021–2026
Table 29. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Players (2021–2026)
Table 30. Global Top Sample Preparation in Genomics, Proteomics, and Epigenomics Players by Tier (Tier 1, Tier 2, and Tier 3), based on Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue, 2025
Table 31. Ranking of Global Top Sample Preparation in Genomics, Proteomics, and Epigenomics Companies by Revenue (US$ Million) in 2025
Table 32. Global 5 Largest Players Market Share by Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue (CR5 and HHI), 2021–2026
Table 33. Global Key Players of Sample Preparation in Genomics, Proteomics, and Epigenomics, Headquarters and Area Served
Table 34. Global Key Players of Sample Preparation in Genomics, Proteomics, and Epigenomics, Products and Applications
Table 35. Global Key Players of Sample Preparation in Genomics, Proteomics, and Epigenomics, Date of General Availability (GA)
Table 36. Mergers and Acquisitions, Expansion Plans
Table 37. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Type (US$ Million), 2021–2026
Table 38. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Type (2021–2026)
Table 39. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Forecasted Market Size by Type (US$ Million), 2027–2032
Table 40. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Type (2027–2032)
Table 41. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (US$ Million), 2021–2026
Table 42. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Application (2021–2026)
Table 43. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Forecasted Market Size by Application (US$ Million), 2027–2032
Table 44. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue Market Share by Application (2027–2032)
Table 45. North America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. North America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (US$ Million), 2021–2026
Table 47. North America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (US$ Million), 2027–2032
Table 48. Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (US$ Million), 2021–2026
Table 50. Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (US$ Million), 2027–2032
Table 51. Asia-Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 52. Asia-Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Region (US$ Million), 2021–2026
Table 53. Asia-Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Region (US$ Million), 2027–2032
Table 54. Latin America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 55. Latin America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (US$ Million), 2021–2026
Table 56. Latin America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (US$ Million), 2027–2032
Table 57. Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 58. Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (US$ Million), 2021–2026
Table 59. Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Country (US$ Million), 2027–2032
Table 60. QIAGEN GmbH Company Details
Table 61. QIAGEN GmbH Business Overview
Table 62. QIAGEN GmbH Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 63. QIAGEN GmbH Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 64. QIAGEN GmbH Recent Development
Table 65. Bio-Rad Laboratories, Inc. Company Details
Table 66. Bio-Rad Laboratories, Inc. Business Overview
Table 67. Bio-Rad Laboratories, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 68. Bio-Rad Laboratories, Inc. Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 69. Bio-Rad Laboratories, Inc. Recent Development
Table 70. Danaher Corporation Company Details
Table 71. Danaher Corporation Business Overview
Table 72. Danaher Corporation Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 73. Danaher Corporation Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 74. Danaher Corporation Recent Development
Table 75. Merck KGaA Company Details
Table 76. Merck KGaA Business Overview
Table 77. Merck KGaA Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 78. Merck KGaA Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 79. Merck KGaA Recent Development
Table 80. PerkinElmer, Inc. Company Details
Table 81. PerkinElmer, Inc. Business Overview
Table 82. PerkinElmer, Inc. Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 83. PerkinElmer, Inc. Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 84. PerkinElmer, Inc. Recent Development
Table 85. BGI Company Details
Table 86. BGI Business Overview
Table 87. BGI Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 88. BGI Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 89. BGI Recent Development
Table 90. Cytiva Company Details
Table 91. Cytiva Business Overview
Table 92. Cytiva Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 93. Cytiva Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 94. Cytiva Recent Development
Table 95. Illumina Company Details
Table 96. Illumina Business Overview
Table 97. Illumina Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 98. Illumina Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 99. Illumina Recent Development
Table 100. Roche Sequencing Solutions Company Details
Table 101. Roche Sequencing Solutions Business Overview
Table 102. Roche Sequencing Solutions Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 103. Roche Sequencing Solutions Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 104. Roche Sequencing Solutions Recent Development
Table 105. New England Biolabs Company Details
Table 106. New England Biolabs Business Overview
Table 107. New England Biolabs Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 108. New England Biolabs Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 109. New England Biolabs Recent Development
Table 110. Thermo Fisher Scientific Company Details
Table 111. Thermo Fisher Scientific Business Overview
Table 112. Thermo Fisher Scientific Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 113. Thermo Fisher Scientific Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 114. Thermo Fisher Scientific Recent Development
Table 115. Miltenyi Biotec Company Details
Table 116. Miltenyi Biotec Business Overview
Table 117. Miltenyi Biotec Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 118. Miltenyi Biotec Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 119. Miltenyi Biotec Recent Development
Table 120. Twist Bioscience Company Details
Table 121. Twist Bioscience Business Overview
Table 122. Twist Bioscience Sample Preparation in Genomics, Proteomics, and Epigenomics Product
Table 123. Twist Bioscience Revenue in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (US$ Million), 2021–2026
Table 124. Twist Bioscience Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Authors List of This Report
List of Figures
Figure 1. Sample Preparation in Genomics, Proteomics, and Epigenomics Picture
Figure 2. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Type: 2025 vs 2032
Figure 4. DNA Sample Preparation Features
Figure 5. RNA Sample Preparation Features
Figure 6. Protein Sample Preparation Features
Figure 7. Epigenetic Modification Targeted Preparation Features
Figure 8. Others Features
Figure 9. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Comparison by Technology Platform (US$ Million), 2021–2032
Figure 10. Sequencing Platform Pretreatment Features
Figure 11. Mass Spectrometry Platform Pretreatment Features
Figure 12. Microarray Hybridization Pretreatment Features
Figure 13. PCR Platform Pretreatment Features
Figure 14. Others Features
Figure 15. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size Comparison by Complexity (US$ Million), 2021–2032
Figure 16. All Components Preparation Features
Figure 17. Subcellular Components Preparation Features
Figure 18. Modified and Enriched Components Preparation Features
Figure 19. Others Features
Figure 20. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size by Application (US$ Million), 2021–2032
Figure 21. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Application: 2025 vs 2032
Figure 22. Academic Institutes, and Government Institutes Case Studies
Figure 23. Hospitals and Clinics Case Studies
Figure 24. Pharmaceutical and Biotechnology Companies Case Studies
Figure 25. Others Case Studies
Figure 26. Sample Preparation in Genomics, Proteomics, and Epigenomics Report Years Considered
Figure 27. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 28. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 29. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Region: 2025 vs 2032
Figure 30. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Players in 2025
Figure 31. Global Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 32. The Top 10 and 5 Players Market Share by Sample Preparation in Genomics, Proteomics, and Epigenomics Revenue in 2025
Figure 33. North America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. North America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Country (2021–2032)
Figure 35. United States Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Canada Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Europe Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Country (2021–2032)
Figure 39. Germany Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. France Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. U.K. Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Italy Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Russia Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Ireland Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Asia-Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Asia-Pacific Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Region (2021–2032)
Figure 47. China Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Japan Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. South Korea Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Southeast Asia Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. India Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Australia & New Zealand Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Latin America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Latin America Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Country (2021–2032)
Figure 55. Mexico Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Brazil Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Middle East & Africa Sample Preparation in Genomics, Proteomics, and Epigenomics Market Share by Country (2021–2032)
Figure 59. Israel Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 60. Saudi Arabia Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 61. UAE Sample Preparation in Genomics, Proteomics, and Epigenomics Market Size YoY Growth (US$ Million), 2021–2032
Figure 62. QIAGEN GmbH Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 63. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 64. Danaher Corporation Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 65. Merck KGaA Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 66. PerkinElmer, Inc. Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 67. BGI Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 68. Cytiva Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 69. Illumina Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 70. Roche Sequencing Solutions Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 71. New England Biolabs Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 72. Thermo Fisher Scientific Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 73. Miltenyi Biotec Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 74. Twist Bioscience Revenue Growth Rate in Sample Preparation in Genomics, Proteomics, and Epigenomics Business (2021–2026)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
